Loading
Fecal Microbiota Transplantation / Clostridioides Difficile Associated Disease / Clostridium Infections · Journal article
Gut Microbes · August 20, 2026
Encouraging direction, but not yet definitive.
This case-control study identifies amino acid-based formula feeding as a notable risk factor for C. difficile-associated disease in infants and toddlers under two years old. The association is mechanistically plausible—AAF-fed infants show reduced faecal Bifidobacteria, organisms that compete with C. difficile—and corroborated by a mouse fecal transplant model showing increased susceptibility to CDAD in recipients of AAF-donor microbiota versus normal formula-donor microbiota.
Case-control study with microbiome analysis and fecal microbiota transplant animal model validation. Infants and toddlers under 2 years of age with CDAD and asymptomatic C. difficile carriers enrolled from Affiliated Hangzhou First People's Hospital of Westlake University, China; informed consent obtained from parents or legal representatives.. Intervention: Amino acid-based formula feeding (exposure examined retrospectively). Compared with: Normal formula feeding and asymptomatic C. difficile carrier status. Affiliated Hangzhou First People's Hospital of Westlake University, Hangzhou, China; cases collected from nine provinces across China.
27 CDAD cases identified in infants and toddlers under 2 years over 2 years (January 2023–March 2025) across nine provinces in China Amino acid-based formula feeding identified as a notable risk factor associated with CDAD development in infants AAF-fed infants exhibit reduced levels of Bifidobacteria in fecal microbiomes compared to normal formula-fed infants
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This work identifies amino acid-based formula as a potential modifiable risk factor for CDAD in a previously poorly understood high-risk age group. Clinicians should consider AAF as a risk indicator in infants presenting with C. difficile-associated gastrointestinal disease, though the small sample size and single-centre design require confirmation before practice recommendations can be made.
A real observation from a sound but limited case-control study examining risk factors for a rare disease in infants, supported by mechanistic microbiome data and animal model findings, but requiring confirmation in larger prospective studies.
As stated by the source record.
Quoted from the source exactly as published.
This work identifies amino acid-based formula as a potential modifiable risk factor for CDAD in a previously poorly understood high-risk age group. Clinicians should consider AAF as a risk indicator in infants presenting with C. difficile-associated gastrointestinal disease, though the small sample size and single-centre design require confirmation before practice recommendations can be made.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Infants and toddlers were previously considered to be exempt from Clostridioides difficile-associated disease (CDAD). However, recent studies reported that Clostridioides difficile (C. difficile) infection can cause severe gastrointestinal symptoms within this age group, yet the influential risk factors related to CDAD in infants remain unknown. Here, we investigated 27 CDAD cases in infants and toddlers under two and found that the amino acid-based formula (AAF) feeding is a notable risk factor closely associated with the development of CDAD in infants. Infants fed with AAF exhibit reduced levels of Bifidobacteria, which were reported to compete with C. difficile, in their fecal microbiomes. Lastly, we found that mice transplanted with feces from AAF-fed infant donors, compared with those from normal formula (NF)-fed donors, were more susceptible to CDAD. These findings shed light on the understanding of variables influencing infant CDAD and offer valuable insights for its prevention.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.